Beresford A P, Macrae P V, Alker D, Kobylecki R J
Pfizer Central Research, Department of Drug Metabolism Sandwich, Kent, UK.
Arzneimittelforschung. 1989 Feb;39(2):201-9.
Metabolism of the dihydropyridine calcium antagonist (R,S)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbony l-5- methoxycarbonyl- 6 -methyl- 1,4-dihydropyridine (amlodipine) has been studied in animals and man using 14C-labelled drug. The metabolite patterns are complex; 18 metabolites have been isolated from rat, dog and human urine. Based on chromatographic and mass-spectral evidence, structures have been proposed for the main metabolites and confirmed by synthesis of unambiguous reference compounds. Comparison of all reference compounds and isolated metabolites was made by gas chromatography-mass spectrometry pressure liquid chromatography on-line thermospray-mass spectrometry of underivatised compounds directly in urine. The metabolites are largely pyridine derivatives. The methods used in structure designation are presented, along with the proposed route of metabolism, which indicates that the metabolic pattern for amlodipine in man has features in common with those of both rat and dog.
已使用14C标记的药物在动物和人体中研究了二氢吡啶类钙拮抗剂(R,S)-2-[(2-氨基乙氧基)甲基]-4-(2-氯苯基)-3-乙氧羰基-5-甲氧羰基-6-甲基-1,4-二氢吡啶(氨氯地平)的代谢情况。代谢产物模式复杂;已从大鼠、狗和人类尿液中分离出18种代谢产物。基于色谱和质谱证据,已为主要代谢产物提出了结构,并通过合成明确的参考化合物进行了确认。通过气相色谱-质谱联用、直接对尿液中未衍生化化合物进行在线热喷雾质谱的高效液相色谱法,对所有参考化合物和分离出的代谢产物进行了比较。代谢产物主要是吡啶衍生物。介绍了用于结构鉴定的方法以及提出的代谢途径,这表明氨氯地平在人体中的代谢模式具有与大鼠和狗的代谢模式相同的特征。